| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) (NCT05136768) | Jun-Lin Yi, MD | 2021-12-01 |
| 68Ga-PSMA PET in the Prostate Cancer (NCT04967001) | Xijing Hospital | 2021-06-01 |
| Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment (NCT04066322) | Fudan University | 2019-08-25 |
| CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases (NCT05261113) | University of Regensburg | 2017-01-01 |
| Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER) (NCT02452294) | University Hospital Tuebingen | 2015-07-01 |
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin (NCT02414269) | Memorial Sloan Kettering Cancer Center | 2015-05-01 |
| Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases (NCT02301858) | Janna Berg | 2013-12-01 |
| S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (NCT01918852) | Dutch Colorectal Cancer Group | 2013-12-01 |
| Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors (NCT02156700) | University Hospital Dubrava | 2013-09-01 |
| Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial (NCT02036008) | Sunnybrook Health Sciences Centre | 2013-08-01 |
| Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer (NCT01759238) | Universitätsklinikum Hamburg-Eppendorf | 2013-05-01 |
| Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. (NCT01844661) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2013-01-01 |
| Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors (NCT01678664) | Federation Francophone de Cancerologie Digestive | 2012-12-01 |
| Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer (NCT01403324) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-09-01 |
| Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. (NCT01442246) | UNICANCER | 2011-07-01 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer (NCT01325142) | University of Michigan | 2010-08-01 |
| Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases (NCT01169129) | Barretos Cancer Hospital | 2010-07-01 |
| Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT (NCT01213758) | University of Aarhus | 2010-06-01 |
| Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer (NCT01091168) | Pierre Fabre Medicament | 2009-07-01 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859) | Amgen | 2009-03-09 |
| Analysis of Tokuhashi Score (NCT01210508) | State University of New York - Upstate Medical University | 2009-03-01 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (NCT00770536) | Amgen | 2009-01-01 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton (NCT00748046) | Bayer | 2008-08-01 |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors (NCT00569036) | Bristol-Myers Squibb | 2008-04-01 |
| A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain (NCT00802659) | Washington University School of Medicine | 2008-03-01 |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) (NCT00446446) | Amgen | 2007-10-30 |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement (NCT00537823) | Washington University School of Medicine | 2007-06-01 |
| Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. (NCT00305188) | Sanofi | 2005-12-01 |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases (NCT00107861) | Biogen | 2005-05-01 |
| Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer (NCT00320320) | Gachon University Gil Medical Center | 2005-04-01 |
| Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer (NCT00265200) | University of Louisville | 2005-02-01 |
| Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma (NCT00102024) | Biogen | 2005-01-01 |
| Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) (NCT00100685) | Abbott | 2005-01-01 |
| Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy (NCT00099970) | PDL BioPharma, Inc. | 2004-12-01 |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy (NCT00083720) | Eli Lilly and Company | 2004-10-01 |
| Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) (NCT00093080) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer (NCT00091832) | Amgen | 2004-09-01 |
| MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma (NCT00094653) | Bristol-Myers Squibb | 2004-09-01 |
| Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer (NCT00089635) | Amgen | 2004-08-01 |
| DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer (NCT00099281) | YM BioSciences | 2004-05-01 |
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer (NCT00095108) | ZymoGenetics | 2004-05-01 |
| BMS-599626 in Patients With Advanced Solid Malignancies (NCT00095537) | Bristol-Myers Squibb | 2004-03-01 |
| A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma (NCT00081614) | Genentech, Inc. | 2004-03-01 |
| Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) (NCT00080262) | R-Pharm | 2004-02-01 |
| Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer (NCT00083304) | Spectrum Pharmaceuticals, Inc | 2004-02-01 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients (NCT00080197) | Eisai Inc. | 2004-02-01 |
| Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer (NCT00113763) | Amgen | 2004-01-01 |
| Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer (NCT00080301) | R-Pharm | 2003-09-01 |
| A Research Study for Patients With Prostate Cancer (NCT00106418) | Celgene | 2003-05-07 |
| Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer (NCT00313872) | Samsung Medical Center | 2003-05-01 |
| A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study (NCT00096967) | Genentech, Inc. | 2002-10-01 |
| XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy (NCT00272051) | Sanofi | 2002-07-01 |
| A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane (NCT00097487) | Genentech, Inc. | 2000-11-30 |
| Iressa Expanded Access Program (EAP) (NCT00034879) | AstraZeneca | 2000-08-01 |
| Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa (NCT03977818) | Institut Bergonié | 1990-01-01 |
| ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer (NCT00034463) | Eli Lilly and Company | |